META: Bulls Eye Key Level for Sept 17 – Swing & Scalp Setups

71
1-Hour Chart Technical View
META is riding a clean ascending channel, holding a steady higher-high/higher-low pattern. Friday’s move left a bullish Change of Character (CHoCH) near $772 and confirmed strength with closes above $779. Current intraday trend is supported by the 9 EMA > 21 EMA alignment, and momentum oscillators (MACD, Stoch) continue to lean bullish with no major divergence yet.

* Immediate Support: $774 and $768 (mid-channel / intraday demand)
* Major Support: $764.7 (strong breakout retest zone)
* Upside Zone: $788–$795 is first key resistance; a break targets the $800 call wall and potentially $820 if momentum accelerates.

GEX & Options Flow
snapshot
Options data shows stacked call gamma above spot:
* Call Walls: $795 (3rd call wall), $800 (highest positive NET GEX & key resistance), then $820.
* Put Defense: $747.5 HVL (09/19) with larger put walls around $720 and $710.
* GEX Bias: Net call gamma dominates, suggesting dealers hedge by buying dips, which often dampens downside volatility and supports gradual grind-ups.

IV Rank is modest (IVR ~8.6) with IVx ~33.9, implying option premiums are relatively low for directional plays.

Trade Thoughts & Suggestions
* Swing Idea: As long as $774 holds, risk-defined swing longs can target $795–$800 with room toward $820 if $800 breaks on volume.
* Scalp Idea: Watch 1-hour re-tests of $779/$774 for quick intraday longs, or fade a failed breakout above $795 if volume thins.
* Risk Zone: A sustained break below $764.7 would flip structure short-term and open $749.5 then $743.7.

Quick Take
META is technically strong with bullish gamma support. For Sept 17, price action favors controlled dip-buys until $800 is tested. Scalp traders can play the $779–$788 range; swing traders can look for $795–$820 extensions.

Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always do your own research and manage risk before trading.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.